Orthopedic Bone Cement Market Expansion: Projected to Hit $1.33Billion with 6.1% CAGR by 2029

How large is the orthopedic bone cement market, and what is its growth trajectory?

The orthopedic bone cement market size has grown strongly in recent years. It will grow from $0.98 $ billion in 2024 to $1.05 $ billion in 2025 at a compound annual growth rate (CAGR) of 6.4%. The growth in the historic period can be attributed to an aging population, a rising incidence of osteoporosis, a rising incidence of joint disorders, increasing healthcare expenditure, increasing awareness, and healthcare access.

The orthopedic bone cement market size is expected to see strong growth in the next few years. It will grow to $1.33 $ billion in 2029 at a compound annual growth rate (CAGR) of 6.1%. The growth in the forecast period can be attributed to growing demand for minimally invasive procedures, rising prevalence of orthopedic disorders, expansion of orthopedic surgery centers, growing investment in healthcare infrastructure, and an and an increase in high-impact sports and activities. Major trends in the forecast period include technological advancements, innovations in bone cement technology, innovations in biodegradable and bioactive cements, the adoption of antibiotic-loaded cements, and the and the development of smart bone cements.

Get Your Free Sample of The Global Orthopedic Bone Cement Market Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=19633&type=smp

What are the key forces behind the orthopedic bone cement market’s growth in recent years?

The increasing incidence of accidents and injuries is expected to propel the growth of the orthopedic bone cement market going forward. The rising incidence of accidents and injuries is driven by factors such as higher traffic volumes, more frequent high-risk activities, distracted driving, and inadequate safety measures. Orthopedic bone cement is used to treat injuries to secure implants and facilitate the repair of fractures and damaged joints, ensuring stability and promoting healing. For instance, in April 2024, according to the report published by the National Highway Traffic Safety Administration (NHTSA), a U.S. government agency responsible for ensuring road safety, around 2.38 million individuals were injured in motor vehicle traffic crashes in 2022, compared to 2.28 million in 2021. Therefore, the increasing incidence of accidents and injuries will drive the growth of the orthopedic bone cement market.

What are the major segments of the orthopedic bone cement market?

The orthopedic bone cementmarket covered in this report is segmented –

1) By Type: Low Viscosity Cements, Medium Viscosity Cements, High Viscosity Cements

2) By Material: Polymethyl Methacrylate (PMMA), Ceramic, Acrylic, Other Materials

3) By End Users: Hospitals, Orthopedic Clinics And Centers, Other End-Users

Subsegments:

1) By Low Viscosity Cements: Single Phase, Two Phase

2) By Medium Viscosity Cements: Hand-Mixed, Pre-Mixed

3) By High Viscosity Cements: Self-Mixed, Pre-Mixed in Syringes/Cartridges

Order your report now for swift delivery

https://www.thebusinessresearchcompany.com/report/orthopedic-bone-cement-global-market-report

Which companies dominate the orthopedic bone cement market?

Major companies operating in the orthopedic bone cement market are Johnson & Johnson Services Inc., 3M Company, Medtronic plc, Stryker Corporation, B. Braun Melsungen AG, Zimmer Biomet Holdings Inc., Smith & Nephew plc, Arthrex Inc., Cook Medical LLC, Enovis Corporation, Globus Medical Inc., Wright Medical Group N.V., Medacta International SA, Orthofix Medical Inc., ATEC Spine Inc., Exactech Inc., Spine Wave Inc., Tecres S.p.A., Somatex Medical Technologies GmbH, Heraeus Medical GmbH, DJO Global Inc., TEKNIMED SAS, G-21 SRL, Kyeron Medical Innovations Inc., Graftys SA

What major trends will shape the orthopedic bone cement market during the forecast period?

Major companies operating in the orthopedic bone cement market are focusing on developing innovative products, such as antibiotic-loaded spacers, to enhance infection control during joint replacement surgeries and improve patient outcomes. Antibiotic-loaded spacers are temporary implants used in orthopedic surgery, particularly in treating infected joint prostheses, such as those in the hip or knee. These spacers are made from bone cement (typically polymethylmethacrylate, or PMMA) mixed with antibiotics. For instance, in November 2023, Biocomposites Ltd., a UK-based medical device company, launched the SYNICEM hip, knee, and shoulder performed spacers, which have demonstrated success in patients undergoing joint surgery. These antibiotic-loaded, preformed spacers address the limitations of traditional intra-operative molded and handmade spacers. They support surgeons during hip, knee, and shoulder revisions by maintaining joint space and effectively treating infections. It is designed with precision for consistent performance and structural integrity. SYNICEM spacers deliver a high local concentration of gentamicin and offer flexible, time-saving solutions for surgeons during procedures. It specializes in bone cement and polymer-based products, utilizing proprietary core polymer production and in-house formulation techniques.

What are the key regional dynamics of the orthopedic bone cement market, and which region leads in market share?

North America was the largest region in the orthopedic bone cement market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the orthopedic bone cement market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

What Does The Orthopedic Bone Cement Market Report 2025 Offer?

The orthopedic bone cement market research report from The Business Research Company offers global market size, growth rate, regional shares, competitor analysis, detailed segments, trends, and opportunities.

Orthopedic bone cement is a medical-grade adhesive used in orthopedic surgeries to stabilize and fixate implants within the body, such as artificial joints and bone fragments. It is commonly used in procedures such as hip and knee replacements to enhance the bond between the implant and the bone, promoting effective healing and stability.

Purchase the exclusive report now to unlock valuable market insights:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=19633

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.

Our flagship product, the Global Market Model, is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.

Contact Us:

The Business Research Company

Europe: +44 207 1930 708

Asia: +91 88972 63534

Americas: +1 315 623 0293

Email: info@tbrc.info

Follow Us On:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

Twitter: https://twitter.com/tbrc_info

Facebook: https://www.facebook.com/TheBusinessResearchCompany

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Blog: https://blog.tbrc.info/

Healthcare Blog: https://healthcareresearchreports.com/

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Leave a Reply

Your email address will not be published. Required fields are marked *